1. Home
  2. HLSQ vs CRIS Comparison

HLSQ vs CRIS Comparison

Compare HLSQ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tessera Defense and Homeland Security Inc. Common Stock

HLSQ

Tessera Defense and Homeland Security Inc. Common Stock

N/A

Current Price

$0.16

Market Cap

972.0K

Sector

Health Care

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.67

Market Cap

976.1K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLSQ
CRIS
Founded
2015
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
972.0K
976.1K
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
HLSQ
CRIS
Price
$0.16
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $42.67
AVG Volume (30 Days)
292.0K
★ 582.9K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 560.42
91.57
EPS
★ 3.56
N/A
Revenue
N/A
★ $9,898,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.04
★ N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.15
$0.33
52 Week High
$7.70
$2,981.00

Technical Indicators

Market Signals
Indicator
HLSQ
CRIS
Relative Strength Index (RSI) 9.04 29.19
Support Level N/A $0.33
Resistance Level $2.85 $5.50
Average True Range (ATR) 0.32 0.09
MACD -0.00 0.45
Stochastic Oscillator 0.63 97.66

Price Performance

Historical Comparison
HLSQ
CRIS

About HLSQ Tessera Defense and Homeland Security Inc. Common Stock

Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: